《大行报告》摩通下调平安好医生(01833.HK)目标价至122元 维持「增持」评级
摩根大通发表报告表示,平安好医生(01833.HK)将於2月2日公布去年业绩,估计其去年下半年复苏强劲,按年增长达39%,对比2020年上半年增长21%。基於互联网医院扩展计划迅速及策略投资升级,平安好医生取得收支平衡的时点会由原来2021年,推迟至介乎2024年至2025年。
该行亦对平安好医生估值延伸至今年年底,按现金流折现率估值,目标价由150元下调至122元。
摩通料平安好医生去年下半年收入达39亿人民币,按年增长39%(估计去年收入按年增长31%至66亿人民币),受益於线上医疗服务增长80%等所推动。
摩通估计平安好医生2020年经调整亏损6.45亿人民币,料今年及明年经调整亏损各13.1亿及9.89亿人民币。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.